Trial Profile
Randomized Trial Investigating Exenatide for Diabetes Prevention in Obese, Insulin-Resistant Individuals With Prediabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Nov 2016 New trial record